Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury.

The present study was undertaken to examine multifaceted therapeutic effects of vascular endothelial growth factor (VEGF) in a rat spinal cord injury (SCI) model, focusing on its capability to stimulate proliferation of endogenous glial progenitor cells. Neural stem cells (NSCs) can be genetically m...

Full description

Bibliographic Details
Main Authors: Hyuk Min Kim, Dong Hoon Hwang, Jong Eun Lee, Seung U Kim, Byung G Kim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2656622?pdf=render
_version_ 1818499701894283264
author Hyuk Min Kim
Dong Hoon Hwang
Jong Eun Lee
Seung U Kim
Byung G Kim
author_facet Hyuk Min Kim
Dong Hoon Hwang
Jong Eun Lee
Seung U Kim
Byung G Kim
author_sort Hyuk Min Kim
collection DOAJ
description The present study was undertaken to examine multifaceted therapeutic effects of vascular endothelial growth factor (VEGF) in a rat spinal cord injury (SCI) model, focusing on its capability to stimulate proliferation of endogenous glial progenitor cells. Neural stem cells (NSCs) can be genetically modified to efficiently transfer therapeutic genes to diseased CNS. We adopted an ex vivo approach using immortalized human NSC line (F3 cells) to achieve stable and robust expression of VEGF in the injured spinal cord. Transplantation of NSCs retrovirally transduced to overexpress VEGF (F3.VEGF cells) at 7 days after contusive SCI markedly elevated the amount of VEGF in the injured spinal cord tissue compared to injection of PBS or F3 cells without VEGF. Concomitantly, phosphorylation of VEGF receptor flk-1 increased in F3.VEGF group. Stereological counting of BrdU+ cells revealed that transplantation of F3.VEGF significantly enhanced cellular proliferation at 2 weeks after SCI. The number of proliferating NG2+ glial progenitor cells (NG2+/BrdU+) was also increased by F3.VEGF. Furthermore, transplantation of F3.VEGF increased the number of early proliferating cells that differentiated into mature oligodendrocytes, but not astrocytes, at 6 weeks after SCI. F3.VEGF treatment also increased the density of blood vessels in the injured spinal cord and enhanced tissue sparing. These anatomical results were accompanied by improved BBB locomotor scores. The multifaceted effects of VEGF on endogenous gliogenesis, angiogenesis, and tissue sparing could be utilized to improve functional outcomes following SCI.
first_indexed 2024-12-10T20:33:01Z
format Article
id doaj.art-f3c55cd9675c4fb79654e5500c2ed972
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T20:33:01Z
publishDate 2009-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f3c55cd9675c4fb79654e5500c2ed9722022-12-22T01:34:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-01-0143e498710.1371/journal.pone.0004987Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury.Hyuk Min KimDong Hoon HwangJong Eun LeeSeung U KimByung G KimThe present study was undertaken to examine multifaceted therapeutic effects of vascular endothelial growth factor (VEGF) in a rat spinal cord injury (SCI) model, focusing on its capability to stimulate proliferation of endogenous glial progenitor cells. Neural stem cells (NSCs) can be genetically modified to efficiently transfer therapeutic genes to diseased CNS. We adopted an ex vivo approach using immortalized human NSC line (F3 cells) to achieve stable and robust expression of VEGF in the injured spinal cord. Transplantation of NSCs retrovirally transduced to overexpress VEGF (F3.VEGF cells) at 7 days after contusive SCI markedly elevated the amount of VEGF in the injured spinal cord tissue compared to injection of PBS or F3 cells without VEGF. Concomitantly, phosphorylation of VEGF receptor flk-1 increased in F3.VEGF group. Stereological counting of BrdU+ cells revealed that transplantation of F3.VEGF significantly enhanced cellular proliferation at 2 weeks after SCI. The number of proliferating NG2+ glial progenitor cells (NG2+/BrdU+) was also increased by F3.VEGF. Furthermore, transplantation of F3.VEGF increased the number of early proliferating cells that differentiated into mature oligodendrocytes, but not astrocytes, at 6 weeks after SCI. F3.VEGF treatment also increased the density of blood vessels in the injured spinal cord and enhanced tissue sparing. These anatomical results were accompanied by improved BBB locomotor scores. The multifaceted effects of VEGF on endogenous gliogenesis, angiogenesis, and tissue sparing could be utilized to improve functional outcomes following SCI.http://europepmc.org/articles/PMC2656622?pdf=render
spellingShingle Hyuk Min Kim
Dong Hoon Hwang
Jong Eun Lee
Seung U Kim
Byung G Kim
Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury.
PLoS ONE
title Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury.
title_full Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury.
title_fullStr Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury.
title_full_unstemmed Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury.
title_short Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury.
title_sort ex vivo vegf delivery by neural stem cells enhances proliferation of glial progenitors angiogenesis and tissue sparing after spinal cord injury
url http://europepmc.org/articles/PMC2656622?pdf=render
work_keys_str_mv AT hyukminkim exvivovegfdeliverybyneuralstemcellsenhancesproliferationofglialprogenitorsangiogenesisandtissuesparingafterspinalcordinjury
AT donghoonhwang exvivovegfdeliverybyneuralstemcellsenhancesproliferationofglialprogenitorsangiogenesisandtissuesparingafterspinalcordinjury
AT jongeunlee exvivovegfdeliverybyneuralstemcellsenhancesproliferationofglialprogenitorsangiogenesisandtissuesparingafterspinalcordinjury
AT seungukim exvivovegfdeliverybyneuralstemcellsenhancesproliferationofglialprogenitorsangiogenesisandtissuesparingafterspinalcordinjury
AT byunggkim exvivovegfdeliverybyneuralstemcellsenhancesproliferationofglialprogenitorsangiogenesisandtissuesparingafterspinalcordinjury